Sleep and Circadian Regulation in Diabetic Retinopathy: The Role of Intrinsically Photosensitive Retinal Ganglion Cells and Melatonin Supplementation
Who is this study for? Patients with Diabetes Mellitus, Diabetic Retinopathy
What treatments are being studied? Melatonin
Status: Recruiting
Location: See location...
Intervention Type: Other, Drug
Study Type: Interventional
Study Phase: Phase 2
SUMMARY
This study explores the use of melatonin in patients with diabetic retinopathy
Eligibility
Participation Requirements
Sex: All
Minimum Age: 40
Maximum Age: 65
Healthy Volunteers: f
View:
• Type 2 diabetes (clinically diagnosed, taking anti-diabetes medications or history of elevated A1C≥6.5%)
• 40-65 years of age
• Diabetic retinopathy of at least moderate degree
Locations
United States
Illinois
University of Illinois at Chicago
RECRUITING
Chicago
Contact Information
Primary
Sirimon Reutrakul
sreutrak@uic.edu
3129966060
Time Frame
Start Date: 2021-02-03
Estimated Completion Date: 2026-06
Participants
Target number of participants: 42
Treatments
Active_comparator: Control
Placebo
Active_comparator: Melatonin
Melatonin
Related Therapeutic Areas
Sponsors
Leads: University of Illinois at Chicago
Collaborators: University of Chicago